EUCRATES BIOMEDICAL ACQU COR's ticker is EUCRU and the CUSIP is G3141W114. A total of 38 filers reported holding EUCRATES BIOMEDICAL ACQU COR in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $752,000 | – | 70,571 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Altium Capital Management LP | 400,000 | $4,264,000 | 1.59% |
| Endurant Capital Management LP | 195,000 | $2,079,000 | 0.75% |
| CVI Holdings, LLC | 355,000 | $3,784,000 | 0.71% |
| Wealthspring Capital LLC | 129,880 | $1,385,000 | 0.69% |
| Sio Capital Management, LLC | 300,000 | $3,198,000 | 0.66% |
| Monashee Investment Management LLC | 300,000 | $3,198,000 | 0.42% |
| Sage Mountain Advisors LLC | 95,970 | $1,023,000 | 0.34% |
| 683 Capital Management, LLC | 600,000 | $6,396,000 | 0.30% |
| LONGFELLOW INVESTMENT MANAGEMENT CO LLC | 200,000 | $2,138,000 | 0.26% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 200,000 | $2,132,000 | 0.23% |